ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 1.348
EU - Europa 1.341
AS - Asia 489
SA - Sud America 17
AF - Africa 7
OC - Oceania 2
Totale 3.204
Nazione #
US - Stati Uniti d'America 1.334
IT - Italia 503
DE - Germania 216
SG - Singapore 201
IE - Irlanda 198
RU - Federazione Russa 173
HK - Hong Kong 168
SE - Svezia 104
GB - Regno Unito 50
CN - Cina 37
ID - Indonesia 30
FI - Finlandia 23
IN - India 19
FR - Francia 16
BR - Brasile 15
CA - Canada 13
CZ - Repubblica Ceca 12
ES - Italia 10
NL - Olanda 8
PH - Filippine 6
PK - Pakistan 5
CH - Svizzera 4
IL - Israele 4
PT - Portogallo 4
TR - Turchia 4
UA - Ucraina 4
VN - Vietnam 4
BD - Bangladesh 3
PL - Polonia 3
RO - Romania 3
AU - Australia 2
BG - Bulgaria 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
IQ - Iraq 2
IR - Iran 2
MA - Marocco 2
MK - Macedonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AT - Austria 1
BE - Belgio 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
JP - Giappone 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
TW - Taiwan 1
Totale 3.204
Città #
Ann Arbor 345
Dublin 188
Hong Kong 168
Frankfurt am Main 166
Singapore 161
Chandler 124
Milan 124
Ashburn 117
New York 113
Fairfield 42
Princeton 40
Rome 32
Santa Clara 31
Wilmington 29
Seattle 27
London 26
Altamura 25
Bologna 25
Jakarta 24
Boardman 23
Perugia 21
Munich 20
Verona 20
Parma 19
Lawrence 18
Woodbridge 17
Helsinki 16
San Diego 15
Houston 14
Washington 14
Cambridge 13
Shanghai 13
Phoenix 9
Toronto 9
Florence 8
Brno 7
Lappeenranta 7
Palermo 7
Slough 7
Andover 6
Assago 6
Brescia 6
Chicago 6
Madrid 6
Monza 6
Osasco 6
Boulogne-Billancourt 5
Carate Brianza 5
Guangzhou 5
Hyderabad 5
Moscow 5
Pavia 5
Prague 5
Pune 5
São Paulo 5
Amsterdam 4
Beijing 4
Bergamo 4
Canelli 4
Kocaeli 4
Los Angeles 4
Naples 4
Tanza 4
Berlin 3
Cesena 3
Cutro 3
Dallas 3
Durg 3
Ferrara 3
Giv‘atayim 3
Huizen 3
Iasi 3
Lissone 3
Lummi Island 3
Magenta 3
Melzo 3
Messina 3
Norwalk 3
Nuremberg 3
Piacenza 3
Québec 3
Ravenna 3
Redmond 3
Shenyang 3
Triuggio 3
Wolfsburg 3
Aarhus 2
Ambāla 2
Anguillara Sabazia 2
Barra Mansa 2
Basel 2
Beni Mellal 2
Cairo 2
Catania 2
Cerignola 2
Courbevoie 2
Cuggiono 2
Desio 2
Duhok 2
Fasano 2
Totale 2.300
Nome #
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 305
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 153
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 148
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 146
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 123
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 101
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 99
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 96
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 88
A Multidatabase study of trajectories of antidepressant use in Italy 85
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 76
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 73
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 67
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 67
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 63
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 59
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 55
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 55
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 54
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 53
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 48
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 48
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 47
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 46
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 46
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 43
Azithromycin use and covid-19: a real-world observational study. 43
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 42
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 40
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 40
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 37
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 37
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 33
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 33
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 32
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 30
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 30
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 30
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 29
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 29
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 28
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 26
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 26
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 25
Editorial: Overcoming boundaries in public health: Advances in international and global health 25
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 24
Epidemiology of SLE in Italy: an observational study using a primary care database 24
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 24
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 23
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 23
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 23
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 23
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 22
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 22
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 22
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 22
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 22
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 21
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 21
Drug-induced Kounis syndrome: A matter of pharmacovigilance 21
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 21
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 21
The Burden of Chronic Heart Failure in Primary Care in Italy 21
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 21
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 20
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 20
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 19
Diabetes is associated with decreased migraine risk: A nationwide cohort study 19
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 19
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 18
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 16
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 15
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 15
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 13
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 12
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 12
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 12
Totale 3.490
Categoria #
all - tutte 20.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 6 1 2
2020/2021330 0 4 7 7 37 68 31 34 33 34 30 45
2021/2022451 51 44 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/2025508 173 332 3 0 0 0 0 0 0 0 0 0
Totale 3.490